Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Feb 27;15(1):26.
doi: 10.1038/s41408-025-01238-4.

Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection

Alexander S Luchinin  1 , Tigran G Gevorkyan  2 , Anastasia A Semenova  2
Affiliations
Editorial

Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection

Alexander S Luchinin et al. Blood Cancer J. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Semenova, Dr. Gevorkyan and Dr. Luchinin report no conflicts of interest related to the submitted work.

Figures

Fig. 1
Fig. 1
Monte Carlo simulation of VGPR+ in patients with MM using VRd as 1st line of therapy.
Fig. 2
Fig. 2
Monte Carlo simulation of VGPR+ in patients with MM using Cilta-cel as 3rd or higher line of therapy.
See this image and copyright information in PMC

References

    1. Cowan AJ, Green DJ, Kwok M, Lee S, Coffey D, Holmberg L, et al. Diagnosis and Management of Multiple Myeloma: A Review. JAMA. 2022;327:464–77. 10.1001/jama.2022.0003. - PubMed
    1. Mateos M-V, Ludwig H, Bazarbachi A, Beksac M, Bladé J, Boccadoro M, et al. Insights on Multiple Myeloma Treatment Strategies. HemaSphere. 2019;3:e163 10.1097/HS9.0000000000000163. - PMC - PubMed
    1. Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Baz R, et al. Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw: JNCCN. 2023;21:1281–301. 10.6004/jnccn.2023.0061. - PubMed
    1. Chacon A, Leleu X, Bobin A. 30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma. Cancers. 2023;15:1929. 10.3390/cancers15071929. - PMC - PubMed
    1. Braunlin M, Belani R, Buchanan J, Wheeling T, Kim K. Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011-2019 oncology clinic electronic health record data. Leuk Lymphoma. 2021;62:377–86. 10.1080/10428194.2020.1827253. - PubMed

Publication types

LinkOut - more resources